`
`nrigaarnx FDAAq:roved Drug Fractals
`
`Ei2A_Hnmi.-.3 i2niumai:u:s" nmmmai
`
`FDA Approved Drug Product:
`
`FAQ5 | nml-uctIons7 I Glossary“ I Contact U89
`
`Eismaii Link
`
`Start Over
`
`Back to Search Results
`
`Back to Overview
`
`Drug Details
`
`Drug l\lamc(s)
`FDA Appllcatlon No.
`Active Ina-edient(s)
`Company
`Orlflnal Approval or Tentative Approval Date
`Chemical Type
`Review Claaelflcatlon
`
`Al.PI'lAGAN P
`(NDA) 021252
`BIIIMONIDINE TARTIIATE
`ALLERGAII
`March 16, 2001
`3 New dosage form
`S Standard review drug
`
`a Therapeutic Equivalents
`
`- Label Information
`
`- Approval History, Letiaere, Reviews, and Related
`Documents
`
`Product: on Application (NDA) #021262
`click on a column header to re-sort the table:
`
`Drug Ilarno Active Ingredients
`
`strength Dosage Form/Route
`
`ALPHAGAN P
`
`BRIMONIDINE TARTRATE
`
`0.15%
`
`SOLUTION/DROPS;OPH11-IALMIC
`
`Marketing
`Status
`Prescription
`
`RLD TE
`Code
`Yes AT
`
`Back in Top | Back to Previous Page | Back to Drugs6iFDA Home
`
`Disdai mer 1°
`
`FDA/Center for Drug Evaluation and Research
`Office of Communications
`Division of Oniine Communications
`Updane Frequency: Daily
`
`Links on lhlo page:
`1.
`ittn:/lwww.addthis.oom/bookmark.php?u5D8-true&v-152&username-fdamain
`
`2.
`
`3.
`
`l'I:l'p://www.addthIs.com/bookmark.php
`
`itlqn://www.fda.gov/defau|t.htm
`
`4. ittp ://www.fda.gov/ Drugs/I nformationorflrugs/defau|t.htm
`
`5. ma:://wwmaocessdala.fda.gov/saipls/cder/drugsatfda/index.cfm
`
`6.
`
`I111: ://www.fda.gov/ Drugs/I nformaflonorflrugs/ucmO75234. him
`
`7. Hip ://www.fda.gov/ Drugs/I nformaflononbrugs/U CM 079874
`
`8.
`
`i'il:t.o://www.fda.gov/Drugs/Information0nDrugs/ucm079436.htm
`
`9. http ://www.a ccedalz .fda.gov/scrl pls/e mai I/cde r/com me ntdrugcatcfm
`
`10. Hip ://www.fda.gov/AboutFDA/Aboui3Thlswebsltn/WebsltePo| lcles/defaul t. hi:m#web
`
`Note: If you need help accessing information in different file formats, see instructions for Downloading Viewers and Players.
`Accessibility Contact FDA Careers FDA Basics FOIA No Fear Act Site Map Transparency Website Policies
`
`mpe1Muw.mou:aialuagwbuImIoduImpdluMnch¢.cmneaum=sorcnDn§)adIs
`
`JU
`
`92
`
`PAGE 1 OF 2
`
`LUPIN v SENJU
`
`IPR2015—0l105
`
`
`
`1or2:m15
`
`DnoI@FDk FDAA.mroved Drug Prochch
`
`U.S. Food and Drug Administration
`10903 New Hampshire Avenue
`Sllver Sprlng, MD 20993
`Ph. 1-888-INFO-FDA (1-888-463-6332)
`Contact FDA
`
`D B ; ....
`'
`FOI’ Government For PFBSS
`
`Combi nation Products Advisory Committees Science & Research Regulatory Information Safety Emergency Preparednes
`International Programs News & Events Tralnlng and Oonunulng Educauon Inspectlors/Compliance Statue & Local Offlclals
`Consumers Industry Health Professionals FDA Archive
`£ U.S. Department of Health a Human Services
`
`Llnks on thls page:
`1. I1t:q3://www.addthIs.com/bookmark.php?u508=true&v=152&username=fdamain
`
`htua ://www .addthis.com/bookma rk. php
`
`http ://www .fda. gov/defaulthhn
`
`http ://www .fda. gov] Drugs]I nformationOnDrugs/default. htm
`
`hm: ://www .accessdata .fda.gov/scrl pts/ode r/drugsatfda/|ndex.cfm
`
`http ://www .fda. gov/Drugs/I nformauononDrugs/ucm075234. htm
`
`http ://www .fda. gov]Drugs]I nformat|on0nDrugs/U CMO79874
`
`http ://www .fda. gov/Drugs/I nformaflon0nDrugs/ucm079436. htm
`
`http ://www .accessdata .fda.gov/scrl pt:/emal I/cder/com mentdrugcat. cfm
`
`Imp ://www .fda. gov/AboutFDA/Aboufihlswebslte/Webs|tePoI lcles/default. htm #web
`
`5w9:49w:>w~
`
`mmJMw.mmss:fln.fiagwhaiflsIo¢rIdr|gsfldafiMm.dmmnafiaFSaud1.mLgDdaib
`
`22
`
`PAGE 2 OF 2